Abstract

Hydrodynamic cavitation and fixed geometry high pressure microchannel processing provide intensive methods for controlling pharmaceutical particles, crystals, emulsions, and lipid vesicles. This article examines the relationships among pressure history, cavitation, energy dissipation, residence time, particle fracture, crystallization, surface stabilization, and critical quality attributes. Top down size reduction, bottom up crystallization, cavitation assisted processing, and liposome manufacture are evaluated using representative data for active pharmaceutical ingredient suspensions, naproxen crystallization, emulsions, nanosuspensions, and liposomal systems. The analysis emphasizes that median particle size alone is insufficient for process assessment. Distribution width and coarse tail, morphology, solid state, encapsulation efficiency, free drug, release, storage stability, contamination, sterility, and equipment condition must also be controlled. Performance depends on pressure and back pressure, pass history, chamber geometry, formulation composition, temperature, dissolved gas, and stabilizer coverage. Scale up should preserve the local processing mechanism and hydraulic history rather than pump pressure alone. A Quality by Design framework integrating orthogonal characterization, process analytical technology, cleaning, wear monitoring, and lifecycle validation is presented for development and manufacturing.